AusBiotech launches National Cell and Gene Manufacturing Blueprint
Posted: 24 July 2023 A new National Cell and Gene Manufacturing Blueprint launched today, outlining how, with a united and coordinated plan, Australia can realise its potential to become a cell and gene (C&G) manufacturing hub for within…
Bacteria discreetly dwelling in throat revealed to be primary source of Strep A transmission
Posted: 24 July 2023 Breakthrough research has found that Group A Streptococcus (GAS) infections are more likely transmitted from asymptomatic throat carriage than skin-to-skin contact in communities with high rates of infection. This major discovery has far-reaching implications…
DMX-200 FSGS ACTION3 Phase 3 Kidney Trial Part 1 Outcome Set for Q1 2024
Posted: 24 July 2023 Dimerix Limited (ASX: DXB) a biopharmaceutical company with a Phase 3 clinical study in inflammatory diseases, today confirmed that the first 72 patients have been randomised in its DMX-200 ACTION3 phase 3 trial in…
DEP® HER2-radiodiagnostic shows imaging benefits
Posted: 24 July 2023 Starpharma (ASX: SPL, OTCQX: SPHRY) today announces that DEP® HER2-zirconium, its HER2-targeted radiodiagnostic candidate, has demonstrated a favourable biodistribution profile, with excellent imaging contrast between tumour and normal tissues, as well as rapid uptake and high levels…
Ginkgo Bioworks Awarded DARPA Contract to Reimagine the Manufacturing of Complex Therapeutic Proteins
Posted: 24 July 2023 The Defense Advanced Research Projects Agency (DARPA) announced that Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, has been awarded a 4-year contract worth up to $18…
First Patient Dosed in STARSTRUCK Study of TLX250 Targeted Radiation Therapy in Combination with Merck Investigational DNA-PK Inhibitor, Peposertib
Posted: 24 July 2023 Telix today announces that the first patient has been dosed in a Phase I study of the Company’s investigational targeted radiation therapy, TLX250, in combination with a Merck KGaA, Darmstadt, Germany (Merck) DNA-dependent protein…
BioCurate and NLC Announce Strategic Alliance for Commercialisation of New Therapies
Posted: 20 July 2023 The two will collaborate on development projects to bring new therapies to market. BioCurate, an independently operated joint venture between The University of Melbourne and Monash University, and NLC, the European Healthtech Venture Builder based in…
Victorian Connected Health Innovation and Commercialisation Centre (CHICC)
Posted: 19 July 2023 Introducing the Victorian Connected Health Innovation and Commercialisation Centre (CHICC) – a co-working, mentoring and workshop space designed specifically for Victorian-based digital and connected health companies! Created to boost the growth of digital and…
ANDHealth extends TGA partnership to accelerate digital health regulatory adoption and commercialisation
Posted: 19 July 2023 ANDHealth, Australia’s leading digital health commercialisation organisation, today announced the extension of its partnership with the Therapeutic Goods Administration (TGA) to support Australia’s fast-growing digital health sector. The extended partnership will see TGA fund…
Medtech Manufacturing Series
Medtech Manufacturing Series In partnership with the Australian Medtech Manufacturing Centre (AMMC), BioMelbourne Network is excited to deliver a six-part seminar series for the Victorian medtech manufacturing sector. Victorian medtech manufacturers produce cutting-edge, high-quality products and have…
Discovery could lead to more treatments to prevent cancer and infectious diseases
Posted: 18 July 2023 Researchers have cracked how a particular type of immune cell develops in the body and protects against infection and disease. And the discovery could help in the development of more preventive treatments, according to…
From science fiction to reality: new bionic limb research redefines possibilities for people with amputations
Posted: 14 July 2023 In a world-first, a patient with an amputation above the elbow has been able to control a bionic hand as if it was his own thanks to new surgical and engineering advancements merging humans…
